Pharma News

BriaCell Therapeutics Corp. , a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces that the U.S. Food and Drug Administration (FDA) has granted Fast...

Combining a retrospective analysis of clinical records with in-depth laboratory studies, researchers at The University of Texas MD Anderson Cancer Center have discovered that vitamin E can enhance...

The U.S. Food and Drug Administration has extended by three months its review of Regeneron Pharmaceuticals Inc's application for the full approval of its COVID-19 antibody therapy, the U.S. drugma...

Amneal Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Biologics License Application (BLA) for bevacizumab-maly, a biosimilar referenci...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Biogen’s Vumerity (diroximel fumarate) for National Health Service (NHS) use for the treatment of relapsing-rem...

Shionogi has confirmed reports that its investigational COVID-19 drug, S-217622, led to fetal abnormalities in a preclinical study. ...

San Diego, Calif.-based Halozyme Therapeutics is purchasing Ewing, N.J.-headquartered Antares Pharma in a deal valued at approximately $960 million.

Bristol Myers Squibb’s blockbuster drug Opdivo (nivolumab) has met its primary endpoint of event-free survival in a phase 3 trial compared to chemotherapy alone in patients with resectable nonsma...

The adaptive immune system identifies and responds to different pathogens that humans experience throughout their lives. 

Yale scientists have uncovered its role in regulating body weight by studying the correlation of a protein called augmentor-alpha with cancer. 

Israel-based RedHill Biopharma said that its dual-action investigational COVID-19 oral antiviral and anti-inflammatory drug opaganib has shown potential efficacy against the Omicron subvariants BA...

Novartis is undertaking a huge restructuring to simplify its organization, and some of its employees will feel the pain.